Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 1/20 | 0.42 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.42 |
| ▸ | HTR2A | P28223 | 4/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2356142 | 0.87 | SLC6A4 (0.49) | SLC6A4HTR2AKCNH2LMNAGAA | |
| SCHEMBL4609960 | 0.86 | CA1 (0.55) | AGTR1LMNACYP1A2KMT2AALDH1A1 | |
| SCHEMBL30010698 | 0.86 | CA1 (0.55) | AGTR1LMNACYP1A2KMT2AALDH1A1 | |
| SCHEMBL14376164 | 0.86 | CA1 (0.55) | AGTR1LMNACYP1A2KMT2AALDH1A1 | |
| SCHEMBL3929903 | 0.86 | CA1 (0.55) | AGTR1LMNACYP1A2KMT2AALDH1A1 | |
| SCHEMBL343860 | 0.86 | CA1 (0.55) | AGTR1LMNACYP1A2KMT2AALDH1A1 | |
| SCHEMBL15515907 | 0.86 | SLC6A4 (0.47) | SLC6A4HTR2AKCNH2LMNAGAA | |
| SCHEMBL19668703 | 0.85 | CASP1 (0.41) | SLC6A4HTR2ACYP1A2KDM4EGAA | |
| SCHEMBL8777075 | 0.84 | HRH1 (0.38) | P2RX3P2RX2SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL8324534 | 0.83 | PTGS2 (0.53) | LMNACYP1A2KDM4EKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0787152-B1 | PROCESS FOR PRODUCING AN AQUEOUS AMINE OXIDE SOLUTION | CHEMIEFASER LENZING AG (AT) | 1998-01-07 | — | — | EP | claimed |
| EP-0787152-A1 | PROCESS FOR PRODUCING AN AQUEOUS AMINE OXIDE SOLUTION | LENZING AKTIENGESELLSCHAFT (AT) | 1997-08-06 | — | — | EP | claimed |
| WO-1997007137-A1 | PROCESS FOR PRODUCING AN AQUEOUS AMINE OXIDE SOLUTION | LENZING AKTIENGESELLSCHAFT (AT) | 1997-02-27 | — | — | WO | claimed |
| EP-2061754-A1 | BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008115999-A1 | BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2008-09-25 | — | — | WO | disclosed |
| US-20080234384-A1 | BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2008-09-25 | — | — | US | disclosed |
| EP-0908478-B1 | Preparation process for flexible polyurethane foams | BASF AG (DE) | 2005-05-11 | — | — | EP | disclosed |
| EP-0908478-A1 | Preparation process for flexible polyurethane foams | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-14 | — | — | EP | disclosed |
| EP-0787152-B1 | PROCESS FOR PRODUCING AN AQUEOUS AMINE OXIDE SOLUTION | CHEMIEFASER LENZING AG (AT) | 1998-01-07 | — | — | EP | disclosed |
| EP-0787152-A1 | PROCESS FOR PRODUCING AN AQUEOUS AMINE OXIDE SOLUTION | LENZING AKTIENGESELLSCHAFT (AT) | 1997-08-06 | — | — | EP | disclosed |
| WO-1997007137-A1 | PROCESS FOR PRODUCING AN AQUEOUS AMINE OXIDE SOLUTION | LENZING AKTIENGESELLSCHAFT (AT) | 1997-02-27 | — | — | WO | disclosed |
| EP-0281941-A2 | Coreactive photoinitiators | CIBA-GEIGY AG (CH) | 1988-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234384-A1 | BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS | FECH, SLC10A1, SLC40A1 | P2RX3 3256/4885P2RX2 3780/4885SLC6A4 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.